July 30, 2020 GenSight Biologics Reports Interim Financial Results for the First Half of 2020 and Provides Operational Update
July 28, 2020 Strongbridge Biopharma plc to Host Second Quarter 2020 Financial Results Conference Call on August 4, 2020
July 27, 2020 CARISMA Therapeutics Announces FDA Clearance of IND Application for First-Ever Engineered Macrophage Immunotherapy
July 22, 2020 GenSight Biologics reports final REALITY natural history study results confirming poor spontaneous recovery for LHON patients with ND4 mutation
July 17, 2020 Aprea Therapeutics Announces Expansion of Clinical Trial Evaluating Eprenetapopt for the Front-Line Treatment of TP53 Mutant Acute Myeloid Leukemia (AML)
July 10, 2020 BONESUPPORT HOLDING AB (publ) – Interim Report Q2 2020 – invitation to conference call and webcast